1. P012 The effect of Oncostatin M on human intestinal organoids. (21st January 2022) Authors: Filidou, E; Kandilogiannakis, L; Kokkotis, G; Tarapatzi, G; Arvanitidis, K; Drygiannakis, I; Valatas, V; Paspaliaris, V; Kolios, G; Bamias, G Journal: Journal of Crohn's and colitis Issue: Volume 16(2022)Supplement 1 Page Start: i141 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. P021 Microbial metabolite receptors as mediators of pathogenic processes in Inflammatory Bowel Disease. (30th January 2023) Authors: Spathakis, M; Dovrolis, N; Tarapatzi, G; Filidou, E; Kandilogiannakis, L; Valatas, V; Drygiannakis, I; Manolopoulos, V G; Kolios, G; Arvanitidis, K; Vradelis, S Journal: Journal of Crohn's and colitis Issue: Volume 17(2023)Supplement 1 Page Start: i191 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
3. P041 The upregulation of tissue factor in colonic mesenchymal cells in active ulcerative colitis is associated with severe and resistant to treatment disease, but tofacitinib has not effect on it. (30th January 2023) Authors: Drygiannakis, I; Tzenaki, N; Archontoulaki, E; Filidou, E; Kandilogiannakis, L; Valatas, V; Kolios, G; Koutroubakis, I E Journal: Journal of Crohn's and colitis Issue: Volume 17(2023)Supplement 1 Page Start: i207 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
4. P045 Oncostatin M induces strong fibrotic and chemokine responses from primary colonic subepithelial myofibroblasts. (27th May 2021) Authors: Kokkotis, G; Tarapatzi, G; Drygiannakis, I; Filidou, E; Kandilogiannakis, L; Arvanitidis, K; Valatas, V; Koutroubakis, I; Vradelis, S; Kolios, G; Bamias, G Journal: Journal of Crohn's and colitis Issue: Volume 15(2021)Supplement 1 Page Start: S154 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
5. P049 Development of human embryonic stem cell-derived intestinal organoids for in vitro studies on intestinal inflammation and fibrosis. (27th May 2021) Authors: Kandilogiannakis, L; Filidou, E; Drygiannakis, I; Tarapatzi, G; Arvanitidis, K; Bamias, G; Valatas, V; Paspaliaris, V; Kolios, G Journal: Journal of Crohn's and colitis Issue: Volume 15(2021)Supplement 1 Page Start: S158 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
6. P067 Human colonic subepithelial myofibroblasts from IBD patients demonstrate a differential expression of Th-related cytokine receptors compared with healthy controls. (25th January 2019) Authors: Bamias, G; Filidou, E; Valatas, V; Drygiannakis, I; Arvanitidis, K; Vradelis, S; Kouklakis, G; Kolios, G Journal: Journal of Crohn's and colitis Issue: Volume 13(2019)Supplement 1 Page Start: S119 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
7. P073 Changes in gut microbial signatures differentiate behavioural Crohn's disease phenotypes; an in silico approach. (16th January 2018) Authors: Dovrolis, N; Kolios, G; Drygiannakis, I; Filidou, E; Kandilogiannakis, L; Arvanitidis, K; Tentes, I; Valatas, V Journal: Journal of Crohn's and colitis Issue: Volume 12:Number 1(2018:Jan.)Supplement 1 Page Start: S129 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗